Open extension study evaluating the long term efficacy, safety and tolerability of oral ziprasidone in the treatment of patients who have successfully completed the previous ziprasidone study A1281031.

Trial Profile

Open extension study evaluating the long term efficacy, safety and tolerability of oral ziprasidone in the treatment of patients who have successfully completed the previous ziprasidone study A1281031.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2008

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Dec 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 24 Aug 2008 Planned end date changed from 1 Jul 2008 to 1 Dec 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top